Article Versions Notes

Liu Y, Hu P, Xu L, Zhang X, Li Z, Li Y, Qiu H. Current Progress on Predictive Biomarkers for Response to Immune Checkpoint Inhibitors in Gastric Cancer: How to Maximize the Immunotherapeutic Benefit? Cancers. 2023; 15(8):2273. https://doi.org/10.3390/cancers15082273

Liu, Yongqing, Pengbo Hu, Liang Xu, Xiuyuan Zhang, Zhou Li, Yiming Li, and Hong Qiu. 2023. "Current Progress on Predictive Biomarkers for Response to Immune Checkpoint Inhibitors in Gastric Cancer: How to Maximize the Immunotherapeutic Benefit?" Cancers 15, no. 8: 2273. https://doi.org/10.3390/cancers15082273

Liu, Y., Hu, P., Xu, L., Zhang, X., Li, Z., Li, Y., & Qiu, H. (2023). Current Progress on Predictive Biomarkers for Response to Immune Checkpoint Inhibitors in Gastric Cancer: How to Maximize the Immunotherapeutic Benefit? Cancers, 15(8), 2273. https://doi.org/10.3390/cancers15082273